Previous Close | 0.0800 |
Open | 0.0850 |
Bid | 0.0800 x 0 |
Ask | 0.0850 x 0 |
Day's Range | 0.0800 - 0.0850 |
52 Week Range | 0.0750 - 0.2850 |
Volume | |
Avg. Volume | 69,701 |
Market Cap | 11.794M |
Beta (5Y Monthly) | 1.77 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1280 |
Earnings Date | Nov 22, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 0.35 |
Indiva Limited (the "Company" or "Indiva") (TSXV: NDVA), announced that it has received notification from Health Canada (the "Notice") of its determination that certain of its lozenges have been improperly classified as an "extract" rather than an "edible" under applicable cannabis regulations. Heath Canada has requested that Indiva cease production of the lozenges. The lozenges subject to this determination are the Indiva Wild Cherry THC Lozenges and Life Lemon THC Lozenges in their 100 mg, 250
LONDON, Ontario, January 20, 2023--Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA) is pleased to announce that further to its press release dated December 22, 2022 it has completed its shares for debt transaction whereby an aggregate of $15,750 of the Company’s outstanding debt was extinguished by way of the issuance of 131,246 common shares in the capital of the Company (the "Shares") at a deemed price of $0.12 per Share. The Shares issued pursuant to the shares for debt transaction are
Vancouver, British Columbia--(Newsfile Corp. - January 17, 2023) - Investor.Events would like to invite the Investment Community to Indiva's Webinar (TSXV: NDVA), which is scheduled for today, Tuesday January 17 at 1pm Pacific, 4pm Eastern. CLICK HERE TO REGISTER - WEBINAR (ZOOM) Registration URL: https://us06web.zoom.us/webinar/register/WN_6llSpbA3S6qDmFHGlneJOg Indiva Jan 17 WebinarTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8294/151584_a9de5